Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
Pregnanetriol is a specific steroid metabolite derived from 17-hydroxyprogesterone, which plays a crucial role in the body's hormonal balance. This compound is primarily excreted in urine, making it a valuable marker for assessing certain endocrine disorders. Pregnanetriol serves as a precursor in the biosynthesis of cortisol, a vital hormone involved in various physiological processes, including metabolism and stress response. Elevated levels of pregnanetriol in the urine can indicate underlying conditions related to the adrenal cortex, such as adrenal hyperplasia, a condition characterized by the overproduction of adrenal hormones, or adrenogenital syndrome, which affects hormone levels and can lead to abnormal sexual development. The measurement of pregnanetriol is typically conducted through a 24-hour urine collection, where a sample volume of 2.1 to 5 mL is analyzed using advanced techniques like gas chromatography mass spectrophotometry. This method allows for precise quantification of pregnanetriol, aiding in the diagnosis and management of adrenal disorders.
© Copyright 2026 Coding Ahead. All rights reserved.
The test for pregnanetriol is indicated for the evaluation of specific adrenal disorders and hormonal imbalances. The following conditions may warrant the performance of this test:
The procedure for measuring pregnanetriol involves several key steps to ensure accurate results. First, a 24-hour urine collection is required. Patients are instructed to collect all urine produced over a 24-hour period, which helps to provide a comprehensive assessment of hormone levels. The total volume of urine collected should be recorded, and a sample of 2.1 to 5 mL is then taken from this collection for analysis. This sample is prepared for testing using gas chromatography mass spectrophotometry, a sophisticated analytical technique that allows for the precise identification and quantification of pregnanetriol in the urine. The use of this method is critical, as it provides high sensitivity and specificity, ensuring that the results are reliable for clinical decision-making.
After the collection and analysis of the urine sample, results are typically available within a few days. Patients may not require any specific post-procedure care, as the test is non-invasive and does not involve any physical intervention. However, it is important for healthcare providers to discuss the results with patients, as elevated levels of pregnanetriol may indicate the need for further diagnostic testing or treatment options. Monitoring and follow-up may be necessary depending on the underlying condition being evaluated.
| Short Descr | ASSAY OF PREGNANETRIOL | Medium Descr | PREGNANETRIOL | Long Descr | Pregnanetriol | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
|
Date
|
Action
|
Notes
|
|---|---|---|
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.